Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 3 (2006), Issue 7 (July)

1. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
   Am J Ophthalmol, 142(1): 95-104. [Abstract] [Full-text]
2. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
   Am J Ophthalmol, 142(1): 10-16. [Abstract] [Full-text]
3. Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].
   Am J Obstet Gynecol, 195(1): 62-71. [Abstract] [Full-text]
4. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
   Obstet Gynecol, 108(1): 141-7. [Abstract] [Full-text]
5. Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
   Obstet Gynecol, 108(1): 33-40. [Abstract] [Full-text]
6. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.
   J Am Coll Cardiol, 48(1): 37-42. [Abstract] [Full-text]
7. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.
   J Biomech Eng, 128(4): 540-53. [Abstract] [Full-text]
8. Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma.
   Cancer Chemother Pharmacol, 58(4): 504-8. [Abstract] [Full-text]
9. Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer.
   Cancer Chemother Pharmacol, 58(4): 509-16. [Abstract] [Full-text]
10. Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues.
    Cancer Chemother Pharmacol, 58(4): 478-86. [Abstract] [Full-text]
11. Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas.
    Cancer Chemother Pharmacol, 58(4): 419-26. [Abstract] [Full-text]
12. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment.
    Environ Microbiol, 8(7): 1137-44. [Abstract] [Full-text]
13. Perioperative administration of antimicrobials associated with elective surgery for cranial cruciate ligament rupture in dogs: 83 cases (2003-2005).
    J Am Vet Med Assoc, 229(1): 92-5. [Abstract] [Full-text]
14. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women.
    Fertil Steril, 86(1): 136-44. [Abstract] [Full-text]
15. Influence of menopausal status and use of hormone replacement therapy on radiation dose from mammography in routine breast screening.
    Br J Radiol, 79(943): 597-602. [Abstract] [Full-text]
16. Intravasation of barium sulphate at barium enema examination.
    Br J Radiol, 79(943): e32-5. [Abstract] [Full-text]
17. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
    N Engl J Med, 355(1): 11-20. [Abstract] [Full-text]
18. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis.
    Neurosurgery, 59(1): 126-33; discussion 126-33. [Abstract] [Full-text]
19. Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy.
    Blood, 108(2): 452-9. [Abstract] [Full-text]
20. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    J Clin Endocrinol Metab, 91(7): 2605-11. [Abstract] [Full-text]
21. Orphan nuclear receptors: therapeutic opportunities in skeletal muscle.
    Am J Physiol Cell Physiol, 291(2): C203-17. [Abstract] [Full-text]
22. Impact of antibiotic restrictions: the physician's perspective.
    Clin Microbiol Infect, 12: 3-9. [Abstract] [Full-text]
23. Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy.
    BJU Int, 98(1): 67-9. [Abstract] [Full-text]
24. Prostate-specific antigen testing in hypogonadism: implications for the safety of testosterone-replacement therapy.
    BJU Int, 98(1): 1-4. [Abstract] [Full-text]
25. Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study.
    Arch Ophthalmol, 124(7): 988-92. [Abstract] [Full-text]
26. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.
    Arch Neurol, 63(7): 945-50. [Abstract] [Full-text]
27. Thrombolytic and newer mechanical device treatment for acute ischemic stroke.
    Expert Rev Neurother, 6(7): 1099-105. [Abstract] [Full-text]
28. Predictors for lower quality of life in the HAART era among HIV-infected men.
    J Acquir Immune Defic Syndr, 42(4): 470-7. [Abstract] [Full-text]
29. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Ann Rheum Dis, 65(8): 1033-7. [Abstract] [Full-text]
30. Does the hormonal situation modify lipid effects by lifestyle factors in middle-aged women? Results from a population-based study of Swedish women: the women's health in the Lund area study.
    Metabolism, 55(8): 1060-6. [Abstract] [Full-text]
31. Intracoronary photodynamic therapy reduces neointimal growth without suppressing re-endothelialisation in a porcine model.
    Heart, 92(8): 1138-44. [Abstract] [Full-text]
32. Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles.
    J Invest Dermatol, 126(8): 1728-32. [Abstract] [Full-text]
33. The influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid.
    J Photochem Photobiol B, 84(2): 161-6. [Abstract] [Full-text]
34. Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin.
    J Photochem Photobiol B, 84(2): 79-88. [Abstract] [Full-text]
35. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
    Br J Haematol, 134(2): 157-70. [Abstract] [Full-text]
36. Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis.
    Circulation, 114(3): 237-41. [Abstract] [Full-text]
37. Aggressive multimodality treatment in transitional cell carcinoma of the parafallopian tube: report of 2 cases and review of the literature.
    Gynecol Oncol, 102(2): 381-5. [Abstract] [Full-text]
38. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Gynecol Oncol, 102(2): 285-91. [Abstract] [Full-text]
39. Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning.
    Gynecol Oncol, 102(2): 270-7. [Abstract] [Full-text]
40. Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer.
    Gynecol Oncol, 102(2): 214-7. [Abstract] [Full-text]
41. Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells.
    Gynecol Oncol, 102(2): 292-9. [Abstract] [Full-text]
42. Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study.
    Gynecol Oncol, 102(2): 226-9. [Abstract] [Full-text]
43. A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study.
    Gynecol Oncol, 102(2): 300-8. [Abstract] [Full-text]
44. Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group study.
    Gynecol Oncol, 102(2): 236-9. [Abstract] [Full-text]
45. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
    JAMA, 296(3): 292-300. [Abstract] [Full-text]
46. High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
    J Clin Oncol, 24(21): 3438-44. [Abstract] [Full-text]
47. Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    J Clin Oncol, 24(21): 3415-22. [Abstract] [Full-text]
48. Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.
    J Clin Oncol, 24(21): 3354-60. [Abstract] [Full-text]
49. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
    J Clin Oncol, 24(21): 3347-53. [Abstract] [Full-text]
50. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    J Clin Oncol, 24(21): 3333-9. [Abstract] [Full-text]
51. A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
    Bone Marrow Transplant, 38(3): 217-22. [Abstract] [Full-text]
52. A novel method for the preparation of biodegradable microspheres for protein drug delivery.
    J R Soc Interface, 3(9): 573-82. [Abstract] [Full-text]
53. Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia.
    Leukemia, 20(8): 1361-7. [Abstract] [Full-text]
54. Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease.
    Br J Ophthalmol, 90(8): 982-6. [Abstract] [Full-text]
55. Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes.
    Br J Ophthalmol, 90(8): 1034-9. [Abstract] [Full-text]
56. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study.
    Lancet Neurol, 5(8): 661-7. [Abstract] [Full-text]
57. Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
    Eur J Haematol, 77(2): 120-7. [Abstract] [Full-text]
58. Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.
    Hypertension, 48(2): 246-53. [Abstract] [Full-text]
59. Prescribers' responses to alerts during medication ordering in the long term care setting.
    J Am Med Inform Assoc, 13(4): 385-90. [Abstract] [Full-text]
60. Case report: activity diagrams for integrating electronic prescribing tools into clinical workflow.
    J Am Med Inform Assoc, 13(4): 391-5. [Abstract] [Full-text]
61. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial.
    J Am Med Inform Assoc, 13(4): 378-84. [Abstract] [Full-text]
62. Three months in the symptom life of a teenage girl undergoing treatment for cancer.
    Res Nurs Health, 29(4): 294-310. [Abstract] [Full-text]
63. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Arch Intern Med, 166(14): 1483-9. [Abstract] [Full-text]
64. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment.
    Neurology, 67(2): 334-6. [Abstract] [Full-text]
65. Combined IV-intra-arterial thrombolysis: a color-coded duplex pilot study.
    Neurology, 67(2): 324-6. [Abstract] [Full-text]
66. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Neurology, 67(2): 311-4. [Abstract] [Full-text]
67. Pulmonary resection after successful downstaging with photodynamic therapy.
    Ann Thorac Surg, 82(2): 722-4. [Abstract] [Full-text]
68. Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax.
    Ann Thorac Surg, 82(2): 457-9. [Abstract] [Full-text]
69. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.
    Radiology, 240(2): 411-8. [Abstract] [Full-text]
70. Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
    J Acquir Immune Defic Syndr, 42(5): 554-61. [Abstract] [Full-text]
71. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial.
    J Acquir Immune Defic Syndr, 42(5): 523-8. [Abstract] [Full-text]
72. A biosocial model of medication use among older women and men in Ismailia, Egypt.
    J Biosoc Sci, 38(5): 577-603. [Abstract] [Full-text]
73. Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults.
    Lancet Infect Dis, 6(8): 496-507. [Abstract] [Full-text]
74. The neurokinin1 receptor antagonist aprepitant as an antiemetic for moderately emetogenic chemotherapy.
    Expert Opin Pharmacother, 7(12): 1653-8. [Abstract] [Full-text]
75. Fludarabine in chronic lymphocytic leukaemia.
    Expert Opin Pharmacother, 7(12): 1641-51. [Abstract] [Full-text]
76. Capecitabine in carcinoma of the pancreas.
    Expert Opin Pharmacother, 7(12): 1633-9. [Abstract] [Full-text]
77. Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel.
    Expert Opin Pharmacother, 7(12): 1627-31. [Abstract] [Full-text]
78. Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke.
    Expert Opin Pharmacother, 7(12): 1571-81. [Abstract] [Full-text]
79. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
    J Clin Oncol, 24(22): 3657-63. [Abstract] [Full-text]
80. Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients.
    J Clin Oncol, 24(22): 3623-8. [Abstract] [Full-text]
81. Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.
    J Clin Oncol, 24(22): 3611-8. [Abstract] [Full-text]
82. Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy.
    J Clin Oncol, 24(22): 3583-9. [Abstract] [Full-text]
83. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    J Clin Oncol, 24(22): 3576-82. [Abstract] [Full-text]
84. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.
    J Clin Oncol, 24(22): 3562-9. [Abstract] [Full-text]
85. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
    J Clin Oncol, 24(22): 3548-54. [Abstract] [Full-text]
86. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    J Clin Oncol, 24(22): 3542-7. [Abstract] [Full-text]
87. Intravascular ultrasound in the drug-eluting stent era.
    J Am Coll Cardiol, 48(3): 421-9. [Abstract] [Full-text]
88. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Ophthalmology, 113(8): 1441-5. [Abstract] [Full-text]
89. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Ophthalmology, 113(8): 1432-40. [Abstract] [Full-text]
90. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
    Invest Ophthalmol Vis Sci, 47(8): 3339-44. [Abstract] [Full-text]
91. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.
    Am J Ophthalmol, 142(2): 335-7. [Abstract] [Full-text]
92. Health literacy and adherence to glaucoma therapy.
    Am J Ophthalmol, 142(2): 223-6. [Abstract] [Full-text]
93. Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels.
    Biomaterials, 27(31): 5440-51. [Abstract] [Full-text]

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.